Formulation, Characterization, and in Vivo Evaluation of Celecoxib-PVP Solid Dispersion Nanoparticles Using Supercritical Antisolvent Process

The aim of this study was to develop celecoxib-polyvinylpyrrolidone (PVP) solid dispersion nanoparticles with and without surfactant using the supercritical antisolvent (SAS) process. The effect of different surfactants such as gelucire 44/14, poloxamer 188, poloxamer 407, Ryoto sugar ester L1695, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ha, Eun-Sol, Choo, Gwang-Ho, Baek, In-Hwan, Kim, Min-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271652/
https://www.ncbi.nlm.nih.gov/pubmed/25486246
http://dx.doi.org/10.3390/molecules191220325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271652/
https://www.ncbi.nlm.nih.gov/pubmed/25486246
http://dx.doi.org/10.3390/molecules191220325

Ejemplares similares